Quantum dot-based detection platform for in vitro diagnostic testing of urine biomarkers. Enables multi-channel composite analysis for early detection of diabetic nephropathy and premature rupture of membranes through dry-reagent immunoassay technology. Supports both clinical laboratory quantificati...
Manufactured by
China
National high-tech enterprise established in 2013, specializing in precision medicine diagnostics. Product lines include diabetic nephropathy tests, maternal and child health diagnostics, cardiovascular disease markers, tumor markers, and monoclonal antibody raw materials. Holds over 40 national patents with total investment of 450 million RMB.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ZIODIA Co., Ltd.
South Korea · 1 relevant product
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Response Biomedical
Canada · 1 relevant product
Shenzhen YHLO Biotech Co., Ltd.
China · 2 relevant products
S&T BioMed CO., LTD.
Taiwan · 2 relevant products
Xenta Biomedical Science Co.,Ltd
China · 3 relevant products
Beijing Zhongjian Antai Diagnostic Co., Ltd.
China · 1 relevant product
Eaglenos Sciences, Inc.
China · 1 relevant product
Shenzhen Homed Medical Device Co., Ltd.
China · 1 relevant product
28 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 44 closest product alternatives
ZIODIA Co., Ltd. · South Korea
A platform for immune diagnosis devices based on Quantum Dot fluorescence measurement mode technology. It includes Quantum Dot labeled detection kits for enhanced sensitivity, precise analysis, and multiplex analysis capabilities. The platform offers both Gold Type and Quantum Dot Type kits with sensitivity down to ng/ml levels and 500-1,000 fold higher accuracy compared to gold standard detection methods.
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Quantum dot fluorescence-based platform for in vitro diagnostic applications. Supports development of various immunological assays with enhanced optical properties and batch consistency.
Guangzhou Wondfo Biotech Co., Ltd. · China
Chemiluminescence diagnostic platform for quantitative and qualitative analysis of biomarkers in patient samples. Delivers sensitive detection capabilities for clinical laboratory and point-of-care applications.
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
Shenzhen YHLO Biotech Co., Ltd. · China
An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Xenta Biomedical Science Co.,Ltd · China
A diagnostic platform featuring high sensitivity and wide detection menu that comprehensively covers critical care, cardiovascular and cerebrovascular diseases, and other key clinical areas. The platform is widely applied in clinical departments such as laboratory medicine, emergency medicine, and ICU, while also suitable for diverse scenarios including primary healthcare facilities, health examination centers, and reproductive centers.
Shenzhen YHLO Biotech Co., Ltd. · China
A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.
Xenta Biomedical Science Co.,Ltd · China
A proprietary dry-phase photoactivated chemiluminescence technology platform for point-of-care testing. Covers cardiovascular, inflammatory, tumor marker, hormone, and infectious disease diagnostics.
Eaglenos Sciences, Inc. · China
Point-of-care testing system for rapid, accurate detection and personalized health assessment. Integrates precision detection technology with health management protocols for decentralized diagnostic applications.
Shenzhen Homed Medical Device Co., Ltd. · China
In vitro diagnostic testing platform for clinical laboratory analysis. Supports disease screening and monitoring across multiple therapeutic areas.
32 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products